New Mammogram-Based Measures Improve Breast Cancer Prediction
New mammogram-based risk measures based on brightness and texture improve breast cancer risk prediction beyond an established measure of mammographic density.
New mammogram-based risk measures based on brightness and texture improve breast cancer risk prediction beyond an established measure of mammographic density.
Several previously FDA-approved medicines were approved for additional uses in November 2020.
Review of patient-reported outcomes identified posttreatment symptoms ranging in severity from pain to bother in women undergoing radiotherapy for breast cancer.
A posttreatment program demonstrated that nurse practitioner-led follow-up visits can be an essential component of radiation therapy.
A study in The Lancet Oncology examined the age when breast cancer screenings commonly begin, and whether researchers feel it should be sooner.
The survival of Black women was highest at ACS-affiliated hospitals for both overall survival and breast cancer–specific survival after adjusting for all covariates.
Breast cancer surgery is safe in women 70 years and older.
Patients with early-stage breast cancer who undergo mastectomy with or without reconstruction are at risk of prolonged opioid use.
Insulin resistance is one factor mediating part of the association between race and poor prognosis in breast cancer.
Previous studies investigated the benefits of CBT delivered by clinical psychologists. In this study, researchers sought to determine its benefits when delivered by breast care nurses trained in the intervention.